Abstract | INTRODUCTION: High-risk neuroblastoma is a deadly disease; poor prognosticators are MYCN-amplification and TERT-overexpression. We hypothesized that Gene Set Enrichment Analysis (GSEA) could identify pathways associated with MYCN-amplification and that inhibition of these pathways could decrease tumor growth. METHODS: We analyzed the Neuroblastoma-Kocak dataset (GSE45547, n = 649) and identified pathways associated with MYCN-amplification. Inhibitors were selected from upregulated gene sets for in vitro cytotoxicity testing using ST16-patient-derived primary neuroblastoma cells and in vivo testing using orthotopic ST16-patient-derived xenografts (PDX) in mice. Tumor volume was measured with ultrasound and tumor sections examined after H&E staining. RESULTS: GSEA identified significantly overexpressed gene sets in MYCN-amplified tumors including MYC targets, cell cycle mitotic genes, TERT associated genes, loss of RB1 gene sets, and E2Fs targets. Several genes were potential Bromodomain-containing protein 4 (Brd4) targets, making Brd4 inhibitors - JQ1, AZD5153 - and cyclin-dependent kinase (Brd4's binding partner) inhibitors - dinaciclib - potential therapeutic agents. JQ1 and dinaciclib were synergistic in inducing cytotoxicity in vitro. Dinaciclib-AZD5153 in vivo decreased tumor size compared to control, and increased tumor lymphocyte infiltration and necrosis on histology. CONCLUSIONS: GSEA is a powerful approach to identify upregulated genes and potential therapeutic targets. Dinaciclib-AZD5153 combination therapy can be effective against MYCN-amplified and TERT-overexpressing neuroblastoma tumors.
|
Authors | Lauren Wood, Min Huang, Jasmine Zeki, Miao Gong, Jordan Taylor, Hiroyuki Shimada, Bill Chiu |
Journal | Journal of pediatric surgery
(J Pediatr Surg)
Vol. 56
Issue 7
Pg. 1199-1202
(Jul 2021)
ISSN: 1531-5037 [Electronic] United States |
PMID | 33838899
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021. Published by Elsevier Inc. |
Chemical References |
- BRD4 protein, human
- Cell Cycle Proteins
- MYCN protein, human
- N-Myc Proto-Oncogene Protein
- Nuclear Proteins
- Transcription Factors
- Cyclin-Dependent Kinases
|
Topics |
- Animals
- Cell Cycle Proteins
(genetics)
- Cell Line, Tumor
- Cyclin-Dependent Kinases
- Gene Expression Regulation, Neoplastic
- Humans
- Mice
- N-Myc Proto-Oncogene Protein
(genetics, metabolism)
- Neuroblastoma
(drug therapy, genetics)
- Nuclear Proteins
(genetics, metabolism)
- Transcription Factors
|